🟢 DKSH is trading 4.05% up today after BNP Paribas upgrade

DKSH is trading at CHF 77.00, up 4.05%, after BNP Paribas upgraded the stock to outperform from neutral and raised its target to CHF 82 from CHF 64.

• On October 19, DKSH agreed to acquire NewBridge Pharmaceuticals for USD 390 million, expanding DKSH Healthcare into 14 MENA markets.
• The deal is subject to approvals and expected to close by Q1 2027; no trading-volume figure was verified.